What is the level of liabilities of Sensorion this year?
Sensorion has a debt balance of 17.14 M EUR this year.
Sensorion Liabilities 2025
Sensorion Liabilities
17.14 M EUR
Ticker
ALSEN.PA
ISIN
FR0012596468
WKN
A14SVV
In 2025, Sensorion's total liabilities amounted to 17.14 M EUR, a 29.57% difference from the 13.23 M EUR total liabilities in the previous year.
Sensorion Aktienanalyse
What does Sensorion do?
The company Sensorion SA is a French biotechnology company that specializes in developing innovative therapies for hearing and balance disorders. It was founded in 2009 and is headquartered in Montpellier. Sensorion SA's business model is based on researching and developing new drugs that can be used to treat inner ear diseases. These diseases often have severe effects on the quality of life and social interaction of those affected and represent a significant unmet medical need. Sensorion SA aims to develop innovative and effective therapies to address this need. The company specializes in two main areas: hearing disorders and balance disorders. In the field of hearing disorders, Sensorion SA focuses on developing drugs to treat sensorineural hearing loss. These disorders can be caused by various factors such as aging, noise exposure, or genetic predisposition and affect the inner ear. Sensorion SA has a promising pipeline of drugs in clinical development based on different mechanisms of action. These drugs aim to protect the inner ear and restore hearing function. In the field of balance disorders, Sensorion SA focuses on developing new drugs to treat dizziness and vestibular disorders. These disorders can be caused by factors such as aging, medications, or neurological diseases and affect the balance system in the inner ear. Sensorion SA also has a promising pipeline of drugs in clinical development in this area. Sensorion SA's products are not yet available on the market as they are still in development and undergoing clinical trials. However, the company works closely with academic and industry partners to test and validate its drugs. The development of new drugs is a lengthy and costly process that can take many years. However, Sensorion SA is confident that its therapies have the potential to improve the lives of many people. Overall, Sensorion SA has a promising business model based on the development of innovative therapies for hearing and balance disorders. The company has a promising pipeline of drugs in clinical development and works closely with partners to test and validate its products. If successful, their drugs could have a significant impact on the lives of people suffering from these diseases. Sensorion ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Sensorion's Liabilities
Sensorion's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Sensorion's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Sensorion's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Sensorion's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Sensorion’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Sensorion stock
What were the liabilities of Sensorion compared to the previous year?
The liabilities of Sensorion have increased by 29.57% increased compared to the previous year.
What are the consequences of high debt for investors of Sensorion?
High liabilities can pose a risk for investors of Sensorion, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Sensorion?
Low liabilities mean that Sensorion has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Sensorion affect the company?
An increase in liabilities of Sensorion can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Sensorion affect the company?
A decrease in the liabilities of Sensorion can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Sensorion?
Some factors that can influence the liabilities of Sensorion include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Sensorion so important for investors?
The liabilities of Sensorion are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Sensorion take to modify the liabilities?
To change its liabilities, Sensorion can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Sensorion pay?
Over the past 12 months, Sensorion paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sensorion is expected to pay a dividend of 0 EUR.
What is the dividend yield of Sensorion?
The current dividend yield of Sensorion is .
When does Sensorion pay dividends?
Sensorion pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Sensorion?
Sensorion paid dividends every year for the past 0 years.
What is the dividend of Sensorion?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Sensorion located?
Sensorion is assigned to the 'Health' sector.
Wann musste ich die Aktien von Sensorion kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Sensorion from 10/8/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 10/8/2025.
When did Sensorion pay the last dividend?
The last dividend was paid out on 10/8/2025.
What was the dividend of Sensorion in the year 2024?
In the year 2024, Sensorion distributed 0 EUR as dividends.
In which currency does Sensorion pay out the dividend?
The dividends of Sensorion are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Sensorion
Our stock analysis for Sensorion Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sensorion Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
